A great advance in public health, ETPharma & more related news here
New Delhi: Japanese biopharmaceutical giant Takeda has secured approval to market its dengue prevention vaccine ‘Qdenga’ in India. The approval granted last week is supported by a local Phase 3 study involving 480 healthy adults, where the vaccine was found to be “tolerated, safe and immunogenic” across the target age group. This is the first…
